1. Home
  2. KRKR vs PFSA Comparison

KRKR vs PFSA Comparison

Compare KRKR & PFSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo 36Kr Holdings Inc.

KRKR

36Kr Holdings Inc.

N/A

Current Price

$4.75

Market Cap

9.5M

ML Signal

N/A

PFSA

Profusa Inc.

N/A

Current Price

$0.19

Market Cap

11.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
KRKR
PFSA
Founded
2010
2009
Country
China
United States
Employees
N/A
N/A
Industry
Business Services
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.5M
11.1M
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
KRKR
PFSA
Price
$4.75
$0.19
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
3.4K
6.8M
Earning Date
09-26-2025
11-19-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$30,966,526.00
N/A
Revenue This Year
$182.55
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
122.22
52 Week Low
$2.76
$0.12
52 Week High
$21.36
$12.76

Technical Indicators

Market Signals
Indicator
KRKR
PFSA
Relative Strength Index (RSI) 40.73 N/A
Support Level $4.11 N/A
Resistance Level $4.85 N/A
Average True Range (ATR) 0.26 0.00
MACD 0.00 0.00
Stochastic Oscillator 43.87 0.00

Price Performance

Historical Comparison
KRKR
PFSA

About KRKR 36Kr Holdings Inc.

36KR Holdings Inc is a holding company and conducts its business mainly through its subsidiaries, a VIE, and subsidiaries of the VIE. The Group is engaging in providing content and business services to new economy participants in the PRC. Its content production process includes content creation, content editing, screening and monitoring, and content distribution. The Group mainly generates revenues from providing online advertising services, enterprise value-added services, and subscription services. The Group's principal operations and geographic markets are substantially located in PRC.

About PFSA Profusa Inc.

Profusa Inc is a clinical-stage digital health and medical technology company focused on developing biosensing solutions to improve health outcomes for patients with a variety of different diseases and conditions. The Company's technology enables the development of bioengineered sensors that are designed to become one with the body to detect and continuously transmit actionable, clinical-grade data for personal and medical use. The Company's first offering in the European Union, the Lumee Oxygen Platform, is designed to report reliable tissue oxygen levels at various regions of interest, both acutely and long-term.

Share on Social Networks: